Document is current
Any future updates will be listed below
-
Authors
Aoyama, Yosuke https://orcid.org/0000-0003-0081-9115
Ozaki, Yukinori https://orcid.org/0000-0002-8064-648X
Kizawa, Rika https://orcid.org/0000-0003-1275-9228
Masuda, Jun
Kawai, Saori
Kurata, Mami
Maeda, Tetsuyo
Yoshida, Kazuyo
Yamashita, Nami https://orcid.org/0000-0001-7182-1090
Nishimura, Meiko https://orcid.org/0000-0002-7285-9426
Hosonaga, Mari
Fukada, Ippei https://orcid.org/0000-0001-7272-3708
Hara, Fumikata
Kobayashi, Takayuki
Takano, Toshimi https://orcid.org/0000-0002-8417-5291
Ueno, Takayuki https://orcid.org/0000-0002-9080-9377
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 25 November 2024
First Online: 7 December 2024
Declarations
:
: Yosuke Aoyama has received honoraria for lectures from TAIHO, MSD, Pfizer, Eli Lilly, and Daiichi Sankyo. Yukinori Ozaki has received honoraria from Pfizer, Kyowa Kirin, Eli Lilly, and Daiichi Sankyo. Meiko Nishimura has received honoraria for lectures from Pfizer, Kyowa Kirin, Eli Lilly, Chugai, and Eizai. Fumikata Hara has received honoraria from Pfizer, Kyowa Kirin, Eli Lilly, Chugai, Daiichi Sankyo, and MSD. Toshimi Takano has received honoraria for lectures from Chugai, Daiichi-Sankyo, and Eli Lilly. Takayuki Ueno has received payments to his institution from Eli Lilly and payments from Chugai, Eisai, AstraZeneca, and Novartis. The other authors did not report any conflicts of interest.
: All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
